Congratulations to the following Harvard Ophthalmology Faculty and Trainees on recieving ARVO Travel Grants:   

• Dina B. K. Abusamra, PhD, Clinical Research Fellow at Mass. Eye and Ear
• ...

On September 2018, a Harvard Ophthalmology delegation traveled to China to meet with PriMed, Peking University Medical Hospital, and the Center of International Cooperation & Communication of Peking...

A study led by Eleftherios Paschalis, PhD, describes a mechanism by which patients with acute ocular injuries become susceptible to progressive neurodegeneration long after the injury has taken...

Researchers have developed a potential new strategy for improving outcomes in corneal transplant surgeries by injecting vasoactive intestinal peptide into the eye. 

A new study led by Harvard...

New research shows that immune cells developed from early exposure to bacteria contribute to vision loss in glaucoma patients.

A research team from Harvard Ophthalmology and MIT has shown...

In a significant advance against drug-resistant superbugs, investigators supported by the Harvard-wide Program on Antibiotic Resistance have identified a new class of synthetic antibiotics that have...

As part of the Association for Research in Vision and Ophthalmology (ARVO) and National Alliance for Eye and Vision Research (NAEVR) Advocacy Day, Magali Saint-Geniez, PhD, and Russell Woods, PhD...

A paper written by Harvard Ophthalmology faculty Ivana K. Kim, MD; Demetrios G. Vavvas, MD, PhD; John B. Miller, MD; Joan W. Miller, MD; Teresa C. Chen, MD; and Deeba Husain, MD; research fellow...

Findings may lead to earlier diagnoses and better prognostic information for patients — and, potentially, new pharmaceutical targets for AMD treatment.

Boston, Mass. — Patients with any stage of...

Regenerating the optic nerve was long considered impossible. But over the last 20 years, advances in the field have instilled confidence in many researchers—including Larry Benowitz, PhD...

Survival of mass extinctions helps to explain near indestructible properties of hospital "superbugs" 

Boston, Mass. — Leading hospital “superbugs,” known as the enterococci, arose from an...

Treating donor tissue with a special cocktail of molecules improves outcomes and promotes survival of high-risk corneal transplants

Boston, Mass. — Treating donor corneas with a cocktail of...

Findings may lead to the development of therapies to prevent damage to the retina, the light-sensitive tissue at the back of the eye.

Boston, Mass. — Chemical eye burns caused by alkali agents not only...

Regulating transcription factor RUNX1 using small molecule drugs a promising novel therapy for diseases of the retina, including advanced diabetic eye disease.

Boston, Mass.— A team led by...

Boston, Mass. — The brains of those who are born blind make new connections in the absence of visual information, resulting in enhanced, compensatory abilities such as a heightened sense of hearing...

May 5-9, 2013 – Seattle, WA

 At this year’s meeting, held in Seattle, Washington from May 5–9, faculty, trainees and research fellows authored 239 abstracts, including 44 papers and 195 research...

From May 1^st to May 5^th, more than 11,000 people attended the Association for Research in Vision and Ophthalmology (ARVO) 2016 Annual Meeting in Seattle, WA. Eye and vision researchers from more...

Janey Wiggs, MD, PhD, is the lead author on the article, “Genome-wide association analysis identifies TXNRD2, ATXN2 and FOXC1 as susceptibility loci for primary open-angle glaucoma” published online...

ONL Therapeutics, Inc., a biopharmaceutical company developing novel therapies for preserving sight in a range of retinal diseases, has announced that Joan W. Miller, MD, Chair of the Department of...

On October 7^th and 8^th, Jason Comander, MD, PhD, and Leo Kim, MD, PhD, participated in the Alliance for Eye and Vision Research (AEVR) Emerging Vision Scientists Program. This program allows...

Gang Luo, PhD, an Associate Scientist of Mass. Eye and Ear/Schepens Eye Institute, recently created the SuperVision+ Goggle app to provide a low cost solution for head mounted vision enhancement...

Two faculty members, Leo Kim, MD, PhD and Jason Comander, MD, PhD, have been selected to participate in the Alliance for Eye and Vision Research (AEVR) Emerging Vision Scientists Program. This program...

Vision researchers at Mass. Eye and Ear/Harvard Medical School (HMS) Department of Ophthalmology have taken a first step in solving a vexing problem: how to preserve photoreceptor cells and avoid...

Boston, MA Researchers at Massachusetts Eye and Ear and Schepens Eye Research Institute have reconstructed an ancient virus that is highly effective at delivering gene therapies to the liver, muscle...

In the 2015 Annual Meeting of the the Association for Research in Vision and Ophthalmology (ARVO), HMS Ophthalmology faculty and trainees will present 255 abstracts, including 35 papers, 188 posters...